First-of-its-kind wellness company Safety Shot
announces clinical trials solidifying the brand's dietary
supplement's ability to significantly reduce Blood Alcohol
Content
JUPITER,
Fla., Aug. 12, 2024 /PRNewswire/ -- Safety Shot,
Inc. (Nasdaq: SHOT) (the "Company"), the revolutionary wellness and
dietary supplement company dedicated to the promotion of
responsible consumption of alcohol, announces significant new
findings from a recent clinical trial conducted at The Center for
Applied Health Sciences ("CAHS"). The double-blind, randomized,
placebo-controlled study evaluated the acute impact of Safety Shot
on consumer's Blood Alcohol Content ("BAC"), successfully
demonstrating remarkable and statistically significant results in
various measures related to alcohol consumption and the subsequent
rapid reduction of BAC.
The study found that within 30 minutes [of the consumption of
Safety Shot], monitored participants reported a highly significant
drop in BAC and peak changes in several of the markers responsible
for the metabolism of alcohol. Participants between the ages of 24
and 46 with bodyweight ranging between 95 and 225 lbs. showed a
dramatic and remarkable difference of 30%-50% faster in the rate at
which alcohol was reduced and cleared from the body with the
consumption of Safety Shot over the placebo. Participants continued
to see measurable drops in successive 30-minute increments,
indicating Safety Shot's proprietary blend of vitamins, minerals
and botanical ingredients is clinically proven as the world's first
formula to aid in the rapid reduction of alcohol within the
body.
"This marks a significant change in consumer behavior by
providing a safer experience to consume alcohol, as well as better
controlled drinking habits to allow for a healthier and more
enjoyable environment for the consumer. We are thrilled to finally
share the news that after nearly a decade of research and
development, our study has successfully confirmed what we have seen
in many of our own non-clinical trials," said Chief Operations
Officer and co-inventor, David Sandler. "These results are
revolutionizing the wellness space as we continue to pioneer the
world's most innovative functional beverages," continued
Sandler.
Key Findings:
- Breath Alcohol Content: Safety Shot proved to
consistently lower breath alcohol content at all measured time
points compared to the placebo.
- Blood Alcohol Content: The study found significant
improvements in BAC in the area under the curve (AUC) and maximum
concentration (Cmax) for ethanol, acetaldehyde, and aldehyde
dehydrogenase levels, favoring Safety Shot.
- Physical Results: Trial participants reported
significantly less head discomfort, reduced fatigue, increased
energy levels, improvements in concentration and reduced feelings
of tiredness at multiple time points throughout the study.
These groundbreaking findings indicate Safety Shot's efficacy in
supporting user metabolism to reduce BAC and ultimately enhance
subjective feelings of well-being and physiological responses
post-alcohol consumption. The study's results are currently being
compiled into a manuscript, which will be submitted to a biomedical
journal for peer review and publication.
Dr. Tim Ziegenfuss, CEO of
CAHS stated, "These results are highly encouraging, showcasing
Safety Shot's potential as a beneficial supplement for individuals
consuming alcohol. The observed reductions in breath and blood
alcohol levels, along with the improvements in subjective feelings
and physiological measures, highlight the promise of Safety Shot in
supporting better outcomes in post-alcohol consumption."
For more information about Safety Shot and the full details of
the study, please visit www.drinksafetyshot.com.
About Safety Shot, Inc.
Safety Shot, Inc. a wellness
and dietary supplement company dedicated to the promotion of
responsible drinking, has developed Safety Shot, the first patented
wellness product on Earth that lowers blood alcohol content by
supporting its metabolism, while boosting clarity, energy and
overall mood. Safety Shot is available for purchase online at
DrinkSafetyShot.com and Amazon. The Company is introducing
business-to-business sales of Safety Shot to distributors,
retailers, restaurants and bars throughout 2024.
About CAHS
The Center for Applied Health Sciences
is an industry leading CRO (Contract Research Organization) that is
committed to providing cost-effective, customized research
solutions to suit the needs of natural products, dietary
supplements, functional food and beverage industries.
www.thecahs.com
Forward-Looking Statements
This press release includes
certain disclosures that contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995 about us and our industry that involve substantial risks
and uncertainties. All statements other than statements of
historical facts contained in this press release, including
statements regarding Safety Shot's ability to develop and
commercialize a product that lowers blood alcohol content, the
timing, progress and results of non-clinical studies and clinical
trials, including our product development plans and strategies,
Safety Shot's future results of operations or financial condition,
business strategy and plans, and objectives of management for
future operations, are forward-looking statements. In some cases,
you can identify forward-looking statements because they contain
words such as "anticipate," "believe," "contemplate," "continue,"
"could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will," or
"would" or the negative of these words or other similar terms or
expressions. Forward-looking statements are based on Safety Shot's
current expectations and are subject to inherent uncertainties,
risks and assumptions that are difficult to predict. Factors that
could cause actual results to differ include, but are not limited
to, our ability to comply with applicable U.S. and foreign laws,
rules, and regulations, product liability claims, our ability to
develop and market Safety Shot and the risks and uncertainties that
are described more fully in the section titled "Risk Factors" in
Safety Shot's annual report on Form 10-K for the fiscal year ended
December 31, 2023, filed with the
Securities and Exchange Commission on April
1, 2024, and its other filings with the Securities and
Exchange Commission. Forward-looking statements contained in this
press release are made as of this date, and Safety Shot undertakes
no duty to update such information except as required under
applicable law.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/safety-shot-announces-powerful-data-analysis-from-recent-clinical-trial-confirming-dramatic-reduction-of-blood-alcohol-content-302219890.html
SOURCE Safety Shot
